Bovilis Nasalgen 3-PMH Vaccine

Supplied By: Merck (196306)


SKU
073150


Unit of
Measure 25 x 1 Dose


Pack
Type Vial


Case
Qty 40

Login
{{promo.PromoName}}

{{promo.PromoText}}

{{promo.StartDate | date : 'MM/dd/yyyy'}} - {{promo.EndDate | date : 'MM/dd/yyyy'}}
May- 2024 Apr- 2024 Mar- 2024 Feb- 2024 Jan- 2024 Dec- 2023 Nov- 2023 Oct- 2023 Sep- 2023 Aug- 2023 Jul- 2023 Jun- 2023 May- 2023
{{purchaseHistoryItem}}


SKU 073150


Size 25 x 1 Dose

Case
Qty 40

Purchase History

May- 2024 {{productPurchaseHistory['073150'][0]}} Oct- 2023 {{productPurchaseHistory['073150'][0+7]}}
Apr- 2024 {{productPurchaseHistory['073150'][1]}} Sep- 2023 {{productPurchaseHistory['073150'][1+7]}}
Mar- 2024 {{productPurchaseHistory['073150'][2]}} Aug- 2023 {{productPurchaseHistory['073150'][2+7]}}
Feb- 2024 {{productPurchaseHistory['073150'][3]}} Jul- 2023 {{productPurchaseHistory['073150'][3+7]}}
Jan- 2024 {{productPurchaseHistory['073150'][4]}} Jun- 2023 {{productPurchaseHistory['073150'][4+7]}}
Dec- 2023 {{productPurchaseHistory['073150'][5]}} May- 2023 {{productPurchaseHistory['073150'][5+7]}}
Nov- 2023 {{productPurchaseHistory['073150'][6]}}
{{promo.PromoName }}

{{promo.PromoText}}

{{promo.StartDate | date : 'MM/dd/yyyy'}} - {{promo.EndDate | date : 'MM/dd/yyyy'}}
Login

Compare Products

{{compareProd.sku}}

{{compareProd.desc}}

{{compareMessage}}

Product Description

NEW NASALGEN® offers young calves an unrivaled BRD defense. With 6.5 months of IBR protection plus BRSV and PI3, NASALGEN 3 is the insurance you need to give your young calves the strong foundation they deserve. And with a unique blue shadow, there’s no second guessing which animals have been vaccinated.

Features & Benefits

  • Designed with an IBR that is not temperature-sensitive, ensuring the vaccine will replicate and protect in any situation
  • Proven safe in pregnant cows and in calves nursing pregnant cows, building a strong foundation for disease protection
  • Mimics natural exposure to the most common causes of pneumonia for an effective immune response